Brief: Ryvu Therapeutics Signs Annex To Framework Deal With Icon Clinical Research Which Ups Total Deal Value To EUR 5.6 Mln
17/12/2021 16:57
Dec 17 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS ANNEX TO FRAMEWORK DEAL WITH ICON CLINICAL RESEARCH
WHICH
UPS TOTAL DEAL VALUE TO EUR 5.6 MILLION
Source text for Eikon: ID:nEM7RzrPMa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project